About Conference
We are all set to introduce and welcome the participants from the global arena to the “5th International Conference on Chronic Diseases” on September 14-15, 2020 in Vienna, Austria. This year Chronic Disease 2020 is based on the theme ‘Exploring the Impact and Intervention”.
Chronic Disease 2020 extends an expert gathering, intended to connect, share and exchange ideas and views for promotion, prevention, treatment and care for chronic diseases. This chronic disease conference majorly focuses on the effective understanding of the disease origin, pathophysiology, risk factors and other clinical interpretations involved.
Experts from the academic and industrial community from all over the world will be joining us to share their most recent research works, patterns and findings. Chronic Disease 2020 will unite the worldwide pioneers in the field to display their investigations and studies along with other researchers. Young researchers can showcase their logical ideas and discoveries through oral sessions.
The 5th International Conference on Chronic Diseases is a two day event that will host about 40+ Scientific and technical sessions on leading and latest research trends related to the field.
Chronic Disease 2020 will provide the following to all the attendees.
-
Creative lectures by speakers.
-
Keynote forums by eminent Professors
-
Poster presentations by Young Researchers
-
Workshops and Symposiums
-
Global Networking opportunities and Collaborations
-
Meet with the editors, society and association members
Target Audience:
-
Cardiologists
-
Nephrologists
-
Neurologists
-
Oncologists
-
Endocrinologists
-
Immunologists
-
Pharmacologists
-
Biotechnologists
-
Researchers
-
Nurse Practitioners
-
Scientists
-
Medical Students
-
Industry Professionals
-
Infection and Quality Control Clinicians
-
Biomedical Researchers and other related doctors
Target Industries:
-
Medical and Pharma Companies
-
Medical Colleges and Hospitals
-
Medical Device Companies
Opportunities
For Researchers & Faculty:
-
Speaker Opportunities
-
Poster Presentations
-
Symposiums
-
Workshops
For Universities, Associations & Societies:
-
Association Partnering
-
Collaboration proposals
-
Academic Partnering
-
Group Participation
For Students & Research Scholars:
-
Poster Competition
-
Young Researcher Forum
-
Group registrations
For Business Delegates:
-
Speaker Opportunities
-
Symposiums
-
Book Launching
-
Networking opportunities
For Companies:
Scientific Sessions
Chronic Disease 2020 will comprise of 17 major tracks that is designed to bring out advances, innovations and improvement in the field by offering a complete trading of knowledge with the participants.
-
One of the fundamental elements of life is the process of respiration. Chronic respiratory diseases (CRD) are a type of chronic diseases involving the airways and various structures of the lungs. More than 300 million individuals are affected by CRD in a year. Some of the common CRDs are asthma, sleep apnea, pulmonary hypertension, respiratory allergies, etc. The risk factors of CRD are uncontrolled tobacco usage, unhealthy diet, and nutrition, air pollution, etc. Control of these factors can help in the prevention of these diseases.
Related Societies:
The National Association of Chronic Disease Directors, American Public Health Association, The American College of Radiation Oncology, The Global Health Workforce Alliance, Australian Disease Management Association, European chronic diseases alliance, Australian institute of health and welfare, Chronic Disease Research Foundation, Australian Chronic Disease Prevention Alliance, Indian Society of Nephrology, American Thoracic Society Forum of International Respiratory Societies, Asian Pacific Society of Cardiology, American Board of Psychiatry and Neurology, American Neurological Association
Related Conferences:
World Cardiology Conference, April 06-07, 2020 Bangkok, Thailand; Global Experts meeting on Chronic Diseases, August 26-27, 2020 Kyoto, Japan; International Conference on Obesity and Chronic Diseases, July 15-16, 2020 Helsinki, Finland; International Conference on Epidemiology & Public Health, September 24-25, 2020 Singapore City, Singapore; International Conference on Pre-Hypertension, Hypertension and Cardio Metabolic Syndrome, April 03-06, 2020, Vilnius, Lithuania; International Conference on Cardiology and Cardiovascular Medicine, April 13-14, Osaka, Japan; Mechanisms to Therapies Innovations in Cancer Metabolism, October 05-08, 2020, Bilbao, Spain
-
Chronic Osteoarticular Diseases (COD) refers to the diseases related to the bones, joints, cartilages, tendons, etc. and are degenerative. Osteoarticular disorders establish one of the fundamental types of health impedance in older people. Majorly these diseases result in the reduction of motion and functions of the musculoskeletal system. The common CODs are arthritis, arthrosis, and other joint-related conditions. CODs are caused due to previous joint injuries, inheritance or abnormal limb development. Diagnosis can be done with the help of medical imaging, physical, clinical and genetic examination.
Related Societies:
American Society of Echocardiography, American Association of Heart Failure Nurses, American Society of Nuclear Cardiology, American Society of Hypertension, Romanian Society of Cardiology, World Federation of Neurology, European Paediatric Neurology Society, British Hypertension Society, The Obesity Society, The Cancer Society of Finland, Australian Cervical Cancer Foundation, Australian Institute of Health and Welfare, Canadian Association of Pharmacy in Oncology, Prostate Cancer Foundation of Australia
Related Conferences:
Euro Congress on Cancer Science & Therapy, May 25-26, 2020 Rome, Italy; Global Congress on Cancer Science and Therapy, August 26-27, 2020, Barcelona, Spain; World Cancer Conference, November 25-26, 2020 Rome, Italy; World Congress on Hypertension, Cardiology, Primary Health and Patient Care, June 18-19, 2020 Geneva, Switzerland; World Congress on Diet, Nutrition and Obesity, April 13-14, 2020 Auckland, New Zealand; IDF Diabetes Complications Congress, December 03-05, 2020, Lisbon, Portugal; Russian National Congress of Cardiology, September 29-October 01, 2020, Kazan, Russia
-
The conditions that involve narrowed or blocked blood vessels are called cardiovascular diseases. These diseases can lead to various forms of heart disease. A majority of cardiovascular diseases are curable if proper treatment is taken. However, the symptoms are usually the same for every disease and it may vary for men and women depending on the heart condition or type. There are acquired and inherited forms of cardiovascular diseases. These can be prevented by making changes in an individual's lifestyle in order to control blood pressure, hypertension, stress, etc.
Related Societies:
The Chronic Disease Prevention Alliance of Canada, National Association of Chronic Disease Directors, European Society for Medical Oncology, European Heart Network, European kidney health alliance, International Diabetes Federation, European COPD Coalition, European Cancer Organisation, European Respiratory Society, European Society of Cardiology, European Society of Hypertension, European Association for the Study of the Liver, European Academy of Allergy and Clinical Immunology, The American Heart Association, Society for Neuroscience
Related Conferences:
European Nephrology Conference, October 12-13, 2020 Zurich, Switzerland; International Conference on Hypertension & Cardiac Health, March 25-26, 2020 Tokyo, Japan; International Conference on Hepatitis & Liver diseases, July 13-14, 2020 Sydney, Australia; Euroscicon Congress on Obesity and Diabetes, November 29-December 01, 2020, Valencia, Spain; Brisbane Chronic Disease Conference, September 07-08, 2020, Brisbane, Queensland; International Conference on Obesity and Weight Loss, May 21-22, 2020; Rome, Italy; Annual Congress on Pulmonology & Respiratory Medicine, March 18-19, 2020 Amsterdam, Netherlands
-
Pain is the bodys typical response to physical trauma or disease. When the pain does not cease even after the injury is healed, it evolves to a condition termed as chronic pain syndrome (CPS). Usually, CPS is categorized as the pain that lasts for more than six months. In most of the cases, CPS is accompanied by depression, disability, emotional stress, etc. The common causes of CPS are autoimmune diseases, arthritis, fibromyalgia, surgical trauma, advanced cancer, etc. These syndromes are associated with the abnormalities between certain glands and the nervous system.
Related Societies:
The National Association of Chronic Disease Directors, American Public Health Association, The American College of Radiation Oncology, The Global Health Workforce Alliance, Australian Disease Management Association, European chronic diseases alliance, Australian institute of health and welfare, Chronic Disease Research Foundation, Australian Chronic Disease Prevention Alliance, Indian Society of Nephrology, American Thoracic Society Forum of International Respiratory Societies, Asian Pacific Society of Cardiology, American Board of Psychiatry and Neurology, American Neurological Association
Related Conferences:
World Cardiology Conference, April 06-07, 2020 Bangkok, Thailand; Global Experts meeting on Chronic Diseases, August 26-27, 2020 Kyoto, Japan; International Conference on Obesity and Chronic Diseases, July 15-16, 2020 Helsinki, Finland; International Conference on Epidemiology & Public Health, September 24-25, 2020 Singapore City, Singapore; International Conference on Pre-Hypertension, Hypertension and Cardio Metabolic Syndrome, April 03-06, 2020, Vilnius, Lithuania; International Conference on Cardiology and Cardiovascular Medicine, April 13-14, Osaka, Japan; Mechanisms to Therapies Innovations in Cancer Metabolism, October 05-08, 2020, Bilbao, Spain
-
Diabetes is a metabolic disease that uses insulin hormones to transport sugar from the blood to the cells which are to be stored or used in the form of energy. Therefore, when the body loses its ability to process blood glucose or blood sugar with the help of insulin, it leads to a condition called diabetes, which implies a high level of glucose accumulation in the body. On the other hand, obesity is a high level of accumulated body fat. Overweight, age, sedentary lifestyle, high blood pressure, hereditary, etc. are some of the risk factors of diabetes and obesity. Both genetic and environmental factors play a vital role in the diagnosis.
Related Societies:
American Society of Echocardiography, American Association of Heart Failure Nurses, American Society of Nuclear Cardiology, American Society of Hypertension, Romanian Society of Cardiology, World Federation of Neurology, European Paediatric Neurology Society, British Hypertension Society, The Obesity Society, The Cancer Society of Finland, Australian Cervical Cancer Foundation, Australian Institute of Health and Welfare, Canadian Association of Pharmacy in Oncology, Prostate Cancer Foundation of Australia
Related Conferences:
Euro Congress on Cancer Science & Therapy, May 25-26, 2020 Rome, Italy; Global Congress on Cancer Science and Therapy, August 26-27, 2020, Barcelona, Spain; World Cancer Conference, November 25-26, 2020 Rome, Italy; World Congress on Hypertension, Cardiology, Primary Health and Patient Care, June 18-19, 2020 Geneva, Switzerland; World Congress on Diet, Nutrition and Obesity, April 13-14, 2020 Auckland, New Zealand; IDF Diabetes Complications Congress, December 03-05, 2020, Lisbon, Portugal; Russian National Congress of Cardiology, September 29-October 01, 2020, Kazan, Russia
-
When the body experiences an abnormal chemical reaction after the normal metabolic process, it leads to metabolic disorders. It is also due to the deficiencies of certain enzymes that are involved in the metabolism of carbohydrates, proteins, amino acids, etc. For some individuals, the body does not have the appropriate enzymes to break down food, while others would not be receiving the nutrition required to process metabolism. These are some factors associated with metabolic disorders. In many cases, failure of the liver or pancreas can cause a metabolic disorder. Most of the metabolic disorders are genetic. They do not exhibit any type of signs or symptoms. However, they depend on the intensity and type of disorder.
Related Societies:
The Chronic Disease Prevention Alliance of Canada, National Association of Chronic Disease Directors, European Society for Medical Oncology, European Heart Network, European kidney health alliance, International Diabetes Federation, European COPD Coalition, European Cancer Organisation, European Respiratory Society, European Society of Cardiology, European Society of Hypertension, European Association for the Study of the Liver, European Academy of Allergy and Clinical Immunology, The American Heart Association, Society for Neuroscience
Related Conferences:
European Nephrology Conference, October 12-13, 2020 Zurich, Switzerland; International Conference on Hypertension & Cardiac Health, March 25-26, 2020 Tokyo, Japan; International Conference on Hepatitis & Liver diseases, July 13-14, 2020 Sydney, Australia; Euroscicon Congress on Obesity and Diabetes, November 29-December 01, 2020, Valencia, Spain; Brisbane Chronic Disease Conference, September 07-08, 2020, Brisbane, Queensland; International Conference on Obesity and Weight Loss, May 21-22, 2020; Rome, Italy; Annual Congress on Pulmonology & Respiratory Medicine, March 18-19, 2020 Amsterdam, Netherlands
-
Acquired Immunodeficiency Syndrome (AIDS) is a chronic, life-threatening disease of the immune system infected by the Human Immunodeficiency Virus (HIV). The CD4 T lymphocytes of the immune system are destroyed by the HIV which makes the body prone to serious infections and conditions. AIDS is an advanced stage of HIV infection which is usually spread through physical contact, blood or any other infected liquid medium. Although AIDS doesn’t have any cure, the risk of getting diagnosed can be decreased with the help of highly effective Antiretroviral Therapy (ART). These help in boosting the immune system, resulting in an increased life expectancy.
Related Societies:
The National Association of Chronic Disease Directors, American Public Health Association, The American College of Radiation Oncology, The Global Health Workforce Alliance, Australian Disease Management Association, European chronic diseases alliance, Australian institute of health and welfare, Chronic Disease Research Foundation, Australian Chronic Disease Prevention Alliance, Indian Society of Nephrology, American Thoracic Society Forum of International Respiratory Societies, Asian Pacific Society of Cardiology, American Board of Psychiatry and Neurology, American Neurological Association
Related Conferences:
World Cardiology Conference, April 06-07, 2020 Bangkok, Thailand; Global Experts meeting on Chronic Diseases, August 26-27, 2020 Kyoto, Japan; International Conference on Obesity and Chronic Diseases, July 15-16, 2020 Helsinki, Finland; International Conference on Epidemiology & Public Health, September 24-25, 2020 Singapore City, Singapore; International Conference on Pre-Hypertension, Hypertension and Cardio Metabolic Syndrome, April 03-06, 2020, Vilnius, Lithuania; International Conference on Cardiology and Cardiovascular Medicine, April 13-14, Osaka, Japan; Mechanisms to Therapies Innovations in Cancer Metabolism, October 05-08, 2020, Bilbao, Spain
-
Renal conditions that can get worse over time are termed as chronic kidney diseases (CKD). This results in the loss of kidney functions. Most of the individuals are prone to CKD. Some of the common complications might be anaemia, cardiovascular diseases, nerve damage, etc. The risk of being diagnosed with CKD increases in patients with diabetes, hypertension, and a history of kidney diseases. CKD involves 5 stages, starting from stage 1 which is mild kidney damage to stage 5 which is complete kidney damage. CKDs can be prevented by bringing changes to an individual’s lifestyle, dietary habits, limiting alcohol consumption, etc. Urine tests, eGFR, and blood pressure analysis are some common diagnostic methods to detect CKD.
Related Societies:
American Society of Echocardiography, American Association of Heart Failure Nurses, American Society of Nuclear Cardiology, American Society of Hypertension, Romanian Society of Cardiology, World Federation of Neurology, European Paediatric Neurology Society, British Hypertension Society, The Obesity Society, The Cancer Society of Finland, Australian Cervical Cancer Foundation, Australian Institute of Health and Welfare, Canadian Association of Pharmacy in Oncology, Prostate Cancer Foundation of Australia
Related Conferences:
Euro Congress on Cancer Science & Therapy, May 25-26, 2020 Rome, Italy; Global Congress on Cancer Science and Therapy, August 26-27, 2020, Barcelona, Spain; World Cancer Conference, November 25-26, 2020 Rome, Italy; World Congress on Hypertension, Cardiology, Primary Health and Patient Care, June 18-19, 2020 Geneva, Switzerland; World Congress on Diet, Nutrition and Obesity, April 13-14, 2020 Auckland, New Zealand; IDF Diabetes Complications Congress, December 03-05, 2020, Lisbon, Portugal; Russian National Congress of Cardiology, September 29-October 01, 2020, Kazan, Russia
-
The liver is a vital organ which is responsible for metabolism, detoxification, energy storage, digestion, and many more tasks. Any sort of disturbances to these functions leads to liver diseases which results in liver damage. Liver disease is also known as hepatic disease. Liver diseases can be caused by viruses, drugs, high alcohol consumption, genetics, poison, etc. Hepatitis is the most common type of viral liver disease in which the liver cells are inflamed due to the infection. Liver function tests, blood tests, ultrasound imaging, liver biopsy are some of the diagnostic methods to detect liver diseases. Hepatic diseases can be treated depending on the causative agent or criteria.
Related Societies:
The Chronic Disease Prevention Alliance of Canada, National Association of Chronic Disease Directors, European Society for Medical Oncology, European Heart Network, European kidney health alliance, International Diabetes Federation, European COPD Coalition, European Cancer Organisation, European Respiratory Society, European Society of Cardiology, European Society of Hypertension, European Association for the Study of the Liver, European Academy of Allergy and Clinical Immunology, The American Heart Association, Society for Neuroscience
Related Conferences:
European Nephrology Conference, October 12-13, 2020 Zurich, Switzerland; International Conference on Hypertension & Cardiac Health, March 25-26, 2020 Tokyo, Japan; International Conference on Hepatitis & Liver diseases, July 13-14, 2020 Sydney, Australia; Euroscicon Congress on Obesity and Diabetes, November 29-December 01, 2020, Valencia, Spain; Brisbane Chronic Disease Conference, September 07-08, 2020, Brisbane, Queensland; International Conference on Obesity and Weight Loss, May 21-22, 2020; Rome, Italy; Annual Congress on Pulmonology & Respiratory Medicine, March 18-19, 2020 Amsterdam, Netherlands
-
The conditions affecting the entire neurological pathway or a single neuron of the nervous system are called neurological disorders. It affects the central and peripheral nervous systems. Usually, many viral, bacterial, parasitic, and fungal infections affect the nervous system. The symptoms of neurological disorders may be due to the immune response or due to the infection itself. There are more than 600 types of neurological disorders with different causes, complications, and results. The causes of these diseases are characterized by congenital causes, perinatal causes, and acquired causes. Many of the disorders are congenital or develop in the early years. In many cases, neurological disorders cannot be cured. However, certain treatments can help in controlling the symptoms.
Related Societies:
The National Association of Chronic Disease Directors, American Public Health Association, The American College of Radiation Oncology, The Global Health Workforce Alliance, Australian Disease Management Association, European chronic diseases alliance, Australian institute of health and welfare, Chronic Disease Research Foundation, Australian Chronic Disease Prevention Alliance, Indian Society of Nephrology, American Thoracic Society Forum of International Respiratory Societies, Asian Pacific Society of Cardiology, American Board of Psychiatry and Neurology, American Neurological Association
Related Conferences:
World Cardiology Conference, April 06-07, 2020 Bangkok, Thailand; Global Experts meeting on Chronic Diseases, August 26-27, 2020 Kyoto, Japan; International Conference on Obesity and Chronic Diseases, July 15-16, 2020 Helsinki, Finland; International Conference on Epidemiology & Public Health, September 24-25, 2020 Singapore City, Singapore; International Conference on Pre-Hypertension, Hypertension and Cardio Metabolic Syndrome, April 03-06, 2020, Vilnius, Lithuania; International Conference on Cardiology and Cardiovascular Medicine, April 13-14, Osaka, Japan; Mechanisms to Therapies Innovations in Cancer Metabolism, October 05-08, 2020, Bilbao, Spain
-
The thyroid gland is responsible for the production of various hormones used to regulate the bodys metabolism. Thyroxine and triiodothyronine are the two major hormones made by the thyroid. When the thyroid gland is affected due to different conditions, it leads to thyroid diseases and it is very common in individuals. There are a wide variety of thyroid diseases ranging from goiter to cancer. The most common thyroid disease occurs due to the abnormal production of thyroid hormones. Thyroid diseases can be diagnosed with the help of biopsy, ultrasound, blood tests, and radioiodine scanning. All thyroid diseases can be treated by bringing the hormone levels back to normal.
Related Societies:
American Society of Echocardiography, American Association of Heart Failure Nurses, American Society of Nuclear Cardiology, American Society of Hypertension, Romanian Society of Cardiology, World Federation of Neurology, European Paediatric Neurology Society, British Hypertension Society, The Obesity Society, The Cancer Society of Finland, Australian Cervical Cancer Foundation, Australian Institute of Health and Welfare, Canadian Association of Pharmacy in Oncology, Prostate Cancer Foundation of Australia
Related Conferences:
Euro Congress on Cancer Science & Therapy, May 25-26, 2020 Rome, Italy; Global Congress on Cancer Science and Therapy, August 26-27, 2020, Barcelona, Spain; World Cancer Conference, November 25-26, 2020 Rome, Italy; World Congress on Hypertension, Cardiology, Primary Health and Patient Care, June 18-19, 2020 Geneva, Switzerland; World Congress on Diet, Nutrition and Obesity, April 13-14, 2020 Auckland, New Zealand; IDF Diabetes Complications Congress, December 03-05, 2020, Lisbon, Portugal; Russian National Congress of Cardiology, September 29-October 01, 2020, Kazan, Russia
-
An inherited blood disease that affects the quality and quantity of hemoglobin is called hemoglobin disorder. These diseases also affect the capacity to carry oxygen throughout the body. Hemoglobin disorders are also known as hemoglobinopathies. When the genes containing the information. There are 2 categories of hemoglobin disorders. The first type is when the gene containing the information to make hemoglobin is mutated to produce abnormal adult hemoglobin and the second type is when the structure of hemoglobin protein is changed. The severity of these diseases varies depending on the fault of globin genes. Ferritin testing, electrophoresis or high-pressure liquid chromatography are some of the relevant tests to identify hemoglobin variants.
Related Societies:
The Chronic Disease Prevention Alliance of Canada, National Association of Chronic Disease Directors, European Society for Medical Oncology, European Heart Network, European kidney health alliance, International Diabetes Federation, European COPD Coalition, European Cancer Organisation, European Respiratory Society, European Society of Cardiology, European Society of Hypertension, European Association for the Study of the Liver, European Academy of Allergy and Clinical Immunology, The American Heart Association, Society for Neuroscience
Related Conferences:
European Nephrology Conference, October 12-13, 2020 Zurich, Switzerland; International Conference on Hypertension & Cardiac Health, March 25-26, 2020 Tokyo, Japan; International Conference on Hepatitis & Liver diseases, July 13-14, 2020 Sydney, Australia; Euroscicon Congress on Obesity and Diabetes, November 29-December 01, 2020, Valencia, Spain; Brisbane Chronic Disease Conference, September 07-08, 2020, Brisbane, Queensland; International Conference on Obesity and Weight Loss, May 21-22, 2020; Rome, Italy; Annual Congress on Pulmonology & Respiratory Medicine, March 18-19, 2020 Amsterdam, Netherlands
Related Conferences:
European Nephrology Conference, October 12-13, 2020 Zurich, Switzerland; International Conference on Hypertension & Cardiac Health, March 25-26, 2020 Tokyo, Japan; International Conference on Hepatitis & Liver diseases, July 13-14, 2020 Sydney, Australia; Euroscicon Congress on Obesity and Diabetes, November 29-December 01, 2020, Valencia, Spain; Brisbane Chronic Disease Conference, September 07-08, 2020, Brisbane, Queensland; International Conference on Obesity and Weight Loss, May 21-22, 2020; Rome, Italy; Annual Congress on Pulmonology & Respiratory Medicine, March 18-19, 2020 Amsterdam, Netherlands
-
When a cell or a group of cells undergoes uncontrollable division or growth, it leads to cancer and might spread to other parts of the body. These can damage and immune system and other conditions that can be fatal. Cancer can occur in any part of the body. The most common type of cancer in women is breast cancer and in men is prostate cancer. Some types of cancers are benign and they are called tumors while other types are malignant. Some of the risk factors of cancer are smoking, excess alcohol consumption, physical inactivity, etc. Some of the causes are preventable. However, appropriate medications and treatment can help in controlling cell growth.
Related Societies:
The National Association of Chronic Disease Directors, American Public Health Association, The American College of Radiation Oncology, The Global Health Workforce Alliance, Australian Disease Management Association, European chronic diseases alliance, Australian institute of health and welfare, Chronic Disease Research Foundation, Australian Chronic Disease Prevention Alliance, Indian Society of Nephrology, American Thoracic Society Forum of International Respiratory Societies, Asian Pacific Society of Cardiology, American Board of Psychiatry and Neurology, American Neurological Association
Related Conferences:
World Cardiology Conference, April 06-07, 2020 Bangkok, Thailand; Global Experts meeting on Chronic Diseases, August 26-27, 2020 Kyoto, Japan; International Conference on Obesity and Chronic Diseases, July 15-16, 2020 Helsinki, Finland; International Conference on Epidemiology & Public Health, September 24-25, 2020 Singapore City, Singapore; International Conference on Pre-Hypertension, Hypertension and Cardio Metabolic Syndrome, April 03-06, 2020, Vilnius, Lithuania; International Conference on Cardiology and Cardiovascular Medicine, April 13-14, Osaka, Japan; Mechanisms to Therapies Innovations in Cancer Metabolism, October 05-08, 2020, Bilbao, Spain
-
Infectious diseases can be easily spread by direct or indirect contact, insect bites, contaminated food or water and is caused by pathogenic microorganisms. The major carriers or infectious diseases are bacteria, viruses, fungi, and parasites. These diseases show a wide range of symptoms. Some diseases show asymptomatic signs while others can be fatal. The pathogenic microorganisms alter or destroy the bodys immune system resulting in severe conditions. Currently, infectious diseases are the leading cause of death in the world. However, new approaches to treat these diseases are implemented. Vaccinations, maintaining a hygienic condition, food safety, etc. are some of the common measures to avoid getting infected.
Related Societies:
American Society of Echocardiography, American Association of Heart Failure Nurses, American Society of Nuclear Cardiology, American Society of Hypertension, Romanian Society of Cardiology, World Federation of Neurology, European Paediatric Neurology Society, British Hypertension Society, The Obesity Society, The Cancer Society of Finland, Australian Cervical Cancer Foundation, Australian Institute of Health and Welfare, Canadian Association of Pharmacy in Oncology, Prostate Cancer Foundation of Australia
Related Conferences:
Euro Congress on Cancer Science & Therapy, May 25-26, 2020 Rome, Italy; Global Congress on Cancer Science and Therapy, August 26-27, 2020, Barcelona, Spain; World Cancer Conference, November 25-26, 2020 Rome, Italy; World Congress on Hypertension, Cardiology, Primary Health and Patient Care, June 18-19, 2020 Geneva, Switzerland; World Congress on Diet, Nutrition and Obesity, April 13-14, 2020 Auckland, New Zealand; IDF Diabetes Complications Congress, December 03-05, 2020, Lisbon, Portugal; Russian National Congress of Cardiology, September 29-October 01, 2020, Kazan, Russia
-
Every 7 out of 10 individuals are affected by chronic diseases. Epidemiology is the study of the transmission of various diseases, studying its causes, insights and wellbeing aspects in a particular population. Epidemiology of chronic diseases includes both biological and social consequences on the vulnerability of the diseases, the genetic influence on the risk factors, etc. Although epidemiology is widely accepted in health care programs, its part in chronic disease is not yet reached well. This is due to the lack of understanding of basic chronic disease epidemiology functions. Epidemiology helps in the management of individuals already affected by diseases. The information obtained through these studies is used in evaluating and planning strategies to prevent and control diseases.
Related Societies:
The Chronic Disease Prevention Alliance of Canada, National Association of Chronic Disease Directors, European Society for Medical Oncology, European Heart Network, European kidney health alliance, International Diabetes Federation, European COPD Coalition, European Cancer Organisation, European Respiratory Society, European Society of Cardiology, European Society of Hypertension, European Association for the Study of the Liver, European Academy of Allergy and Clinical Immunology, The American Heart Association, Society for Neuroscience
Related Conferences:
European Nephrology Conference, October 12-13, 2020 Zurich, Switzerland; International Conference on Hypertension & Cardiac Health, March 25-26, 2020 Tokyo, Japan; International Conference on Hepatitis & Liver diseases, July 13-14, 2020 Sydney, Australia; Euroscicon Congress on Obesity and Diabetes, November 29-December 01, 2020, Valencia, Spain; Brisbane Chronic Disease Conference, September 07-08, 2020, Brisbane, Queensland; International Conference on Obesity and Weight Loss, May 21-22, 2020; Rome, Italy; Annual Congress on Pulmonology & Respiratory Medicine, March 18-19, 2020 Amsterdam, Netherlands
-
Clinical trials are research studies where researchers test for new treatment options, preventive methods or interventions to diagnose, treat and manage various medical conditions. These are medical, surgical, and behavioral research investigations executed on human volunteers which are designed to provide favorable outcomes. There are 2 major types of clinical trials namely interventional and observational. Appropriate regulatory authorities closely supervise studies involving medical or therapeutic interventions on people. Clinical trials for various chronic diseases are administered for assessing more than one medication. There are 4 phases of clinical trials.
Related Societies:
The National Association of Chronic Disease Directors, American Public Health Association, The American College of Radiation Oncology, The Global Health Workforce Alliance, Australian Disease Management Association, European chronic diseases alliance, Australian institute of health and welfare, Chronic Disease Research Foundation, Australian Chronic Disease Prevention Alliance, Indian Society of Nephrology, American Thoracic Society Forum of International Respiratory Societies, Asian Pacific Society of Cardiology, American Board of Psychiatry and Neurology, American Neurological Association
Related Conferences:
World Cardiology Conference, April 06-07, 2020 Bangkok, Thailand; Global Experts meeting on Chronic Diseases, August 26-27, 2020 Kyoto, Japan; International Conference on Obesity and Chronic Diseases, July 15-16, 2020 Helsinki, Finland; International Conference on Epidemiology & Public Health, September 24-25, 2020 Singapore City, Singapore; International Conference on Pre-Hypertension, Hypertension and Cardio Metabolic Syndrome, April 03-06, 2020, Vilnius, Lithuania; International Conference on Cardiology and Cardiovascular Medicine, April 13-14, Osaka, Japan; Mechanisms to Therapies Innovations in Cancer Metabolism, October 05-08, 2020, Bilbao, Spain
-
Medical diagnosis is performed to detect the diseases with the help of any signs and symptoms. Diagnosis is usually a better way for patient care. Over the years, the diagnosing criteria for chronic diseases have been steadily growing. An early diagnosis is important for the management of chronic diseases. Therapeutics includes various pharmacological and medical device-based techniques. The global market brings innovations for the treatment of chronic diseases. One such advancement is the digital therapeutics where treatments are offered through digital devices like phones, apps, sensors, etc. Online programs help patients bring changes to their illness through text messages and other digital facilities.
Related Societies:
American Society of Echocardiography, American Association of Heart Failure Nurses, American Society of Nuclear Cardiology, American Society of Hypertension, Romanian Society of Cardiology, World Federation of Neurology, European Paediatric Neurology Society, British Hypertension Society, The Obesity Society, The Cancer Society of Finland, Australian Cervical Cancer Foundation, Australian Institute of Health and Welfare, Canadian Association of Pharmacy in Oncology, Prostate Cancer Foundation of Australia
Related Conferences:
Euro Congress on Cancer Science & Therapy, May 25-26, 2020 Rome, Italy; Global Congress on Cancer Science and Therapy, August 26-27, 2020, Barcelona, Spain; World Cancer Conference, November 25-26, 2020 Rome, Italy; World Congress on Hypertension, Cardiology, Primary Health and Patient Care, June 18-19, 2020 Geneva, Switzerland; World Congress on Diet, Nutrition and Obesity, April 13-14, 2020 Auckland, New Zealand; IDF Diabetes Complications Congress, December 03-05, 2020, Lisbon, Portugal; Russian National Congress of Cardiology, September 29-October 01, 2020, Kazan, Russia
Market Analysis
Chronic Diseases are generally progressive and are long term. Currently, it is one of the significant causes of physical impairment and deaths worldwide. These diseases can be prevented or controlled with the help of vaccinations or treated using appropriate medications. Risk factors like tobacco usage, sedentary lifestyle, abnormal dietary habits, and drug abuse are some of the major factors of chronic diseases. These diseases tend to become more common with increasing age. Choosing a healthy lifestyle, exercising, and quitting smoking can help in preventing and controlling chronic diseases.
The worldwide market for chronic disease management, device technologies and innovations, and therapeutic methods are expected to develop from $340 billion of every 2019 to $490 billion by 2024, at a CAGR of 7.2% from 2019 through 2024. Chronic disease management incorporates various medications and medical device-based strategies that are used for the management of various diseases. The chronic disease management market is estimated to reach about 5000 million USD in 2025 with a 14.5% CAGR. Chronic disease management of these diseases consists of a specific set of interventions that are majorly aimed at providing excellent healthcare and a better quality of life to patients. Chronic disease management includes a variety of interpretations like guidelines for the self-management of disease conditions, suggestions for a healthy lifestyle, multidisciplinary care, creating awareness about various diseases.
The growth of the chronic disease management market is driven by the rising awareness concerning life-threatening diseases and healthcare expenditure. Chronic diseases account for about 70% of deaths worldwide. Among which the most common medical condition would be ischemic heart disease and diabetes. The global chronic disease market is divided into 4 categories namely, outcomes, delivery mode, applications, and user. The outcomes incorporate educational, implementation, consulting and others. Delivery mode consists of cloud-based, on-premises and web-based. Applications include arthritis, cardiovascular diseases, diabetes, cancer, etc. Finally, the users are the providers, payers, and others.
Geographically the chronic disease market is divided into America, Europe, Asia-Pacific, Middle East, and Africa. America is the largest contributor to the increasing prevalence of chronic diseases, increased research funding for pharmaceutical and biotech industries, etc. Europe is the second-largest contributor to the increasing health problems and conditions and the rising population. In addition to this, the increasing healthcare expenditure is driving market growth and development. Asia Pacific chronic disease market is expected to grow to the rising population and the increase in demand for advances in technological treatments. Middle East and Africa contribute a low share to the chronic disease market due to the less availability of healthcare facilities and low income. People living in underdeveloped countries lack the awareness of new trends and advances in therapeutics. However, the market is anticipated to grow with the increasing hospitals and demand for medical products.
The 5th International Conference on Chronic Disease is expected to encourage more remarkable collaboration to connect and associate with individuals for exchanging observations and perspectives for a better understanding of the origin, advancement, clinical and interpretation science to transfer possible cure for chronic diseases.
Past Conference Report
We take the privilege of sharing with you the grand success of the “4th International Conference on Chronic Diseases” which was held in Paris, France on February 17-18, 2020. The conference highlighted the theme, “Health Promotion and Disease Prevention”. We extend our sincere gratitude and appreciation for the support from our Organizing Committee Members, Media Partners, Collaborators, and Participants for making this event a successful one.
We believe this Chronic Diseases conference was one of the best platforms to have a discussion of innovative researches and developments in the field.
We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. It is our pleasure to have shared a great relationship and collaboration with all these Attendees, associations and we hope to see even greater support in our upcoming events.
If you have any feedback for us for future consideration or improvement of this conference, you can drop your feedbacks at, chronicdiseases@pulsusmeet.com
